

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 6.60072172 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 6.60072172 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.60072172 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.60072172 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.60072172 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 6.60072172 |
| 7 | positive regulation of interferon-alpha production (GO:0032727) | 5.50493123 |
| 8 | oligosaccharide catabolic process (GO:0009313) | 5.30835520 |
| 9 | glycosphingolipid catabolic process (GO:0046479) | 5.29504320 |
| 10 | regulation of interferon-alpha production (GO:0032647) | 5.20906904 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.20446636 |
| 12 | response to peptidoglycan (GO:0032494) | 5.17830245 |
| 13 | cellular response to thyroid hormone stimulus (GO:0097067) | 5.06188660 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.86230290 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.79480339 |
| 16 | glycolipid catabolic process (GO:0019377) | 4.76008534 |
| 17 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.66205481 |
| 18 | response to host immune response (GO:0052572) | 4.66205481 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.58609854 |
| 20 | regulation of macrophage chemotaxis (GO:0010758) | 4.50060046 |
| 21 | microglial cell activation (GO:0001774) | 4.49332207 |
| 22 | response to muramyl dipeptide (GO:0032495) | 4.46521454 |
| 23 | positive regulation of leukocyte degranulation (GO:0043302) | 4.29072996 |
| 24 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.25406312 |
| 25 | ceramide catabolic process (GO:0046514) | 4.21958423 |
| 26 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.19507419 |
| 27 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.18845782 |
| 28 | response to host (GO:0075136) | 4.18845782 |
| 29 | response to host defenses (GO:0052200) | 4.18845782 |
| 30 | type I interferon signaling pathway (GO:0060337) | 4.17108443 |
| 31 | cellular response to type I interferon (GO:0071357) | 4.17108443 |
| 32 | response to type I interferon (GO:0034340) | 4.16691000 |
| 33 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.98842372 |
| 34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.98651415 |
| 35 | amino sugar catabolic process (GO:0046348) | 3.96087740 |
| 36 | positive regulation of interferon-beta production (GO:0032728) | 3.95902336 |
| 37 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.95467274 |
| 38 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.93026472 |
| 39 | positive regulation of mast cell degranulation (GO:0043306) | 3.93026472 |
| 40 | N-acetylneuraminate metabolic process (GO:0006054) | 3.93007898 |
| 41 | I-kappaB phosphorylation (GO:0007252) | 3.92260025 |
| 42 | response to thyroid hormone (GO:0097066) | 3.88810390 |
| 43 | response to interferon-alpha (GO:0035455) | 3.88756204 |
| 44 | positive regulation of mast cell activation (GO:0033005) | 3.85398999 |
| 45 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.82335868 |
| 46 | natural killer cell mediated immunity (GO:0002228) | 3.82335868 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 3.82030295 |
| 48 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.81026366 |
| 49 | membrane lipid catabolic process (GO:0046466) | 3.77382837 |
| 50 | regulation of mast cell degranulation (GO:0043304) | 3.75392534 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 3.75061067 |
| 52 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.74912067 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.73122539 |
| 54 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.61942730 |
| 55 | positive regulation of heat generation (GO:0031652) | 3.57615170 |
| 56 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.57360198 |
| 57 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.55507288 |
| 58 | granulocyte activation (GO:0036230) | 3.54306554 |
| 59 | positive regulation of interleukin-12 production (GO:0032735) | 3.53378111 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 3.49436103 |
| 61 | neutrophil activation (GO:0042119) | 3.48045412 |
| 62 | respiratory burst (GO:0045730) | 3.47320346 |
| 63 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.46974504 |
| 64 | macrophage activation (GO:0042116) | 3.45842554 |
| 65 | cellular response to virus (GO:0098586) | 3.45815197 |
| 66 | regulation of monocyte chemotaxis (GO:0090025) | 3.45692713 |
| 67 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45644885 |
| 68 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.44104230 |
| 69 | sphingolipid catabolic process (GO:0030149) | 3.43562538 |
| 70 | protein localization to endosome (GO:0036010) | 3.38649234 |
| 71 | detection of molecule of bacterial origin (GO:0032490) | 3.38276222 |
| 72 | regulation of antigen processing and presentation (GO:0002577) | 3.35816341 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 3.34522176 |
| 74 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.33839064 |
| 75 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.33732565 |
| 76 | negative regulation of viral genome replication (GO:0045071) | 3.32990659 |
| 77 | barbed-end actin filament capping (GO:0051016) | 3.32954331 |
| 78 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.30911971 |
| 79 | monocyte chemotaxis (GO:0002548) | 3.30845592 |
| 80 | cellular response to interferon-beta (GO:0035458) | 3.27814929 |
| 81 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.27249875 |
| 82 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.27150278 |
| 83 | regulation of podosome assembly (GO:0071801) | 3.25234650 |
| 84 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.24334900 |
| 85 | regulation of cholesterol storage (GO:0010885) | 3.24132623 |
| 86 | regulation of mast cell activation (GO:0033003) | 3.22063857 |
| 87 | regulation of RIG-I signaling pathway (GO:0039535) | 3.21946536 |
| 88 | apoptotic cell clearance (GO:0043277) | 3.21538174 |
| 89 | regulation of mononuclear cell migration (GO:0071675) | 3.21178520 |
| 90 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.20615842 |
| 91 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.20360894 |
| 92 | cellular response to arsenic-containing substance (GO:0071243) | 3.19590991 |
| 93 | cellular response to exogenous dsRNA (GO:0071360) | 3.17884679 |
| 94 | positive regulation of type 2 immune response (GO:0002830) | 3.17609503 |
| 95 | keratan sulfate catabolic process (GO:0042340) | 3.16201126 |
| 96 | superoxide anion generation (GO:0042554) | 3.13612546 |
| 97 | negative regulation of interleukin-12 production (GO:0032695) | 3.13602395 |
| 98 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.10240862 |
| 99 | T-helper 1 type immune response (GO:0042088) | 3.10175043 |
| 100 | regulation of fever generation (GO:0031620) | 3.09985326 |
| 101 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.09575981 |
| 102 | negative regulation of interleukin-17 production (GO:0032700) | 3.07460788 |
| 103 | cytokine secretion (GO:0050663) | 3.05873881 |
| 104 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.04375828 |
| 105 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.04375828 |
| 106 | histamine secretion (GO:0001821) | 3.03818820 |
| 107 | neutrophil mediated immunity (GO:0002446) | 3.02297831 |
| 108 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.01305518 |
| 109 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.01061345 |
| 110 | regulation of interleukin-12 production (GO:0032655) | 3.00920582 |
| 111 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.00561005 |
| 112 | detection of external biotic stimulus (GO:0098581) | 3.00483328 |
| 113 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.99226012 |
| 114 | germinal center formation (GO:0002467) | 2.98740684 |
| 115 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.98520706 |
| 116 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.97010518 |
| 117 | adenosine receptor signaling pathway (GO:0001973) | 2.96027546 |
| 118 | leukocyte mediated cytotoxicity (GO:0001909) | 2.95416477 |
| 119 | positive regulation of cholesterol efflux (GO:0010875) | 2.95284813 |
| 120 | positive regulation of macrophage cytokine production (GO:0060907) | 2.95012774 |
| 121 | phagosome maturation (GO:0090382) | 2.94437144 |
| 122 | modulation by symbiont of host cellular process (GO:0044068) | 2.93824066 |
| 123 | positive regulation of response to biotic stimulus (GO:0002833) | 2.93728624 |
| 124 | regulation of interferon-beta production (GO:0032648) | 2.93068445 |
| 125 | macrophage differentiation (GO:0030225) | 2.93004672 |
| 126 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.90712006 |
| 127 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.90648793 |
| 128 | defense response to protozoan (GO:0042832) | 2.90280584 |
| 129 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.88359630 |
| 130 | reactive oxygen species biosynthetic process (GO:1903409) | 2.87907752 |
| 131 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.87253348 |
| 132 | positive regulation of chemokine production (GO:0032722) | 2.85783914 |
| 133 | B cell mediated immunity (GO:0019724) | 2.85008342 |
| 134 | pinocytosis (GO:0006907) | 2.83664362 |
| 135 | negative regulation of lipid storage (GO:0010888) | 2.83329986 |
| 136 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.80857597 |
| 137 | positive regulation of humoral immune response (GO:0002922) | 2.79721712 |
| 138 | lysosome organization (GO:0007040) | 2.79675146 |
| 139 | lytic vacuole organization (GO:0080171) | 2.79675146 |
| 140 | regulation of chemokine biosynthetic process (GO:0045073) | 2.79536682 |
| 141 | regulation of activation of Janus kinase activity (GO:0010533) | 2.78861699 |
| 142 | response to interferon-beta (GO:0035456) | 2.77537039 |
| 143 | defense response to virus (GO:0051607) | 2.77070100 |
| 144 | regulation of interleukin-17 production (GO:0032660) | 2.76285310 |
| 145 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.75052431 |
| 146 | detection of other organism (GO:0098543) | 2.75049549 |
| 147 | cellular response to interferon-gamma (GO:0071346) | 2.75029188 |
| 148 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.74639486 |
| 149 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.74209213 |
| 150 | positive regulation of regulated secretory pathway (GO:1903307) | 2.73999272 |
| 151 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.73106937 |
| 152 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.71760805 |
| 153 | cellular extravasation (GO:0045123) | 2.69951251 |
| 154 | positive regulation of extracellular matrix organization (GO:1903055) | 2.68737411 |
| 155 | regulation of vitamin metabolic process (GO:0030656) | 2.67424934 |
| 156 | detection of biotic stimulus (GO:0009595) | 2.66921727 |
| 157 | regulation of regulated secretory pathway (GO:1903305) | 2.66637663 |
| 158 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.66017919 |
| 159 | response to acidic pH (GO:0010447) | 2.63421174 |
| 160 | cellular response to lipopolysaccharide (GO:0071222) | 2.62633126 |
| 161 | peptide catabolic process (GO:0043171) | 2.62317865 |
| 162 | eosinophil chemotaxis (GO:0048245) | 2.61494448 |
| 163 | positive regulation of interleukin-6 production (GO:0032755) | 2.61359508 |
| 164 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.61279774 |
| 165 | cellular response to molecule of bacterial origin (GO:0071219) | 2.59483191 |
| 166 | regulation of early endosome to late endosome transport (GO:2000641) | 2.57071840 |
| 167 | positive regulation of cholesterol transport (GO:0032376) | 2.56217467 |
| 168 | positive regulation of sterol transport (GO:0032373) | 2.56217467 |
| 169 | myeloid dendritic cell differentiation (GO:0043011) | 2.55376893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.30747860 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.95839675 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.17480636 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.14153072 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.61185600 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.29299103 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.17960733 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.74559610 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.61335501 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.43114655 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.94476713 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92200970 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.83402892 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.64918533 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.62111050 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.58994985 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.30437944 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23919316 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20563891 |
| 20 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.01759537 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.01511011 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.97459285 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.92232567 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88376653 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.77437390 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76793746 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.76391944 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.75871006 |
| 29 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.75321797 |
| 30 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.74519239 |
| 31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.74314050 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70466007 |
| 33 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.68890220 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68760711 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60265768 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59017301 |
| 37 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54610779 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.52711749 |
| 39 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.48280681 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47517776 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47275102 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41686173 |
| 43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.39058446 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37451556 |
| 45 | MYB_26560356_Chip-Seq_TH2_Human | 1.35051849 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34280658 |
| 47 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32836861 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31278836 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.28577180 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.26552230 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25428097 |
| 52 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22096718 |
| 53 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20427954 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15956796 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13738589 |
| 56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12540487 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12150035 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09902136 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08818727 |
| 60 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08671187 |
| 61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08072276 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06837464 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04790556 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04212335 |
| 65 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02702177 |
| 66 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01388200 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00842548 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00577482 |
| 69 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00155354 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00112393 |
| 71 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99957773 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97156480 |
| 73 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96107582 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95515301 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94997532 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93519982 |
| 77 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91859132 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.90333720 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88213103 |
| 80 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.87372047 |
| 81 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87366409 |
| 82 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87129076 |
| 83 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86891958 |
| 84 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.85762735 |
| 85 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.85443422 |
| 86 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85102962 |
| 87 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83497239 |
| 88 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83497239 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83330868 |
| 90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83083864 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82432700 |
| 92 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82416211 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81782377 |
| 94 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81237344 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80903338 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80903338 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.80842200 |
| 98 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.79046858 |
| 99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76099419 |
| 100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75768792 |
| 101 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75508937 |
| 102 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.74774956 |
| 103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73945174 |
| 104 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72275837 |
| 105 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71495628 |
| 106 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70537724 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70366472 |
| 108 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.70270724 |
| 109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69956528 |
| 110 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67480629 |
| 111 | UTX_26944678_Chip-Seq_JUKART_Human | 0.66320753 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65511797 |
| 113 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.64792129 |
| 114 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.63748513 |
| 115 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.63611341 |
| 116 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.63230903 |
| 117 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62423408 |
| 118 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.61518694 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.61361482 |
| 120 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.61340577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.53545912 |
| 2 | MP0009785_altered_susceptibility_to | 3.57621023 |
| 3 | MP0003436_decreased_susceptibility_to | 3.45860037 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.25643756 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.13946393 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.13859009 |
| 7 | MP0006082_CNS_inflammation | 3.08823664 |
| 8 | MP0002419_abnormal_innate_immunity | 3.07690792 |
| 9 | MP0001790_abnormal_immune_system | 2.95740073 |
| 10 | MP0005387_immune_system_phenotype | 2.95740073 |
| 11 | MP0000685_abnormal_immune_system | 2.95425808 |
| 12 | MP0003303_peritoneal_inflammation | 2.93607577 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.86954092 |
| 14 | MP0005025_abnormal_response_to | 2.84920055 |
| 15 | MP0004510_myositis | 2.81052725 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.64599249 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.58866046 |
| 18 | MP0001800_abnormal_humoral_immune | 2.57102015 |
| 19 | MP0005671_abnormal_response_to | 2.44188588 |
| 20 | MP0002723_abnormal_immune_serum | 2.42757265 |
| 21 | MP0003724_increased_susceptibility_to | 2.38228466 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.35676321 |
| 23 | MP0009278_abnormal_bone_marrow | 2.22047647 |
| 24 | MP0001819_abnormal_immune_cell | 2.08695238 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.04890054 |
| 26 | MP0004947_skin_inflammation | 2.03944470 |
| 27 | MP0002420_abnormal_adaptive_immunity | 2.02986564 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.95009319 |
| 29 | MP0009764_decreased_sensitivity_to | 1.93435550 |
| 30 | MP0001853_heart_inflammation | 1.90705775 |
| 31 | MP0002254_reproductive_system_inflammat | 1.80908780 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.73202080 |
| 33 | MP0008469_abnormal_protein_level | 1.72488624 |
| 34 | MP0005451_abnormal_body_composition | 1.71210843 |
| 35 | MP0009840_abnormal_foam_cell | 1.68313250 |
| 36 | MP0002405_respiratory_system_inflammati | 1.64311059 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.63894010 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.61634550 |
| 39 | MP0003448_altered_tumor_morphology | 1.58166216 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.57482539 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.57482539 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.57110642 |
| 43 | MP0006054_spinal_hemorrhage | 1.51951231 |
| 44 | MP0000920_abnormal_myelination | 1.50040840 |
| 45 | MP0003075_altered_response_to | 1.49020414 |
| 46 | MP0002006_tumorigenesis | 1.48484744 |
| 47 | MP0003329_amyloid_beta_deposits | 1.47285006 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.46928158 |
| 49 | MP0000716_abnormal_immune_system | 1.46922480 |
| 50 | MP0000343_altered_response_to | 1.46344232 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.42401182 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.38978764 |
| 53 | MP0002877_abnormal_melanocyte_morpholog | 1.38511478 |
| 54 | MP0002398_abnormal_bone_marrow | 1.35703819 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.34245210 |
| 56 | MP0005310_abnormal_salivary_gland | 1.29515112 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.28189752 |
| 58 | MP0010307_abnormal_tumor_latency | 1.27974356 |
| 59 | MP0002090_abnormal_vision | 1.27437347 |
| 60 | MP0000604_amyloidosis | 1.26296894 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.26039726 |
| 62 | MP0003690_abnormal_glial_cell | 1.22472697 |
| 63 | MP0000689_abnormal_spleen_morphology | 1.20251760 |
| 64 | MP0000015_abnormal_ear_pigmentation | 1.20224718 |
| 65 | MP0009763_increased_sensitivity_to | 1.17833320 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 1.17692094 |
| 67 | MP0008004_abnormal_stomach_pH | 1.17443394 |
| 68 | MP0000858_altered_metastatic_potential | 1.16971725 |
| 69 | MP0002429_abnormal_blood_cell | 1.14142161 |
| 70 | MP0008260_abnormal_autophagy | 1.11663812 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.05800820 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 1.04903363 |
| 73 | MP0002722_abnormal_immune_system | 1.04079956 |
| 74 | MP0003566_abnormal_cell_adhesion | 1.03753559 |
| 75 | MP0005076_abnormal_cell_differentiation | 1.03571681 |
| 76 | MP0003279_aneurysm | 1.03249722 |
| 77 | MP0000371_diluted_coat_color | 1.01565326 |
| 78 | MP0005166_decreased_susceptibility_to | 0.99756696 |
| 79 | MP0005257_abnormal_intraocular_pressure | 0.99753042 |
| 80 | MP0001542_abnormal_bone_strength | 0.99499151 |
| 81 | MP0010386_abnormal_urinary_bladder | 0.96632995 |
| 82 | MP0005390_skeleton_phenotype | 0.94879557 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 0.94746793 |
| 84 | MP0005165_increased_susceptibility_to | 0.93317158 |
| 85 | MP0010234_abnormal_vibrissa_follicle | 0.92347220 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 0.91302101 |
| 87 | MP0004883_abnormal_blood_vessel | 0.88552906 |
| 88 | MP0005365_abnormal_bile_salt | 0.88512956 |
| 89 | MP0003634_abnormal_glial_cell | 0.87339227 |
| 90 | MP0004808_abnormal_hematopoietic_stem | 0.85818681 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 0.85672844 |
| 92 | MP0003091_abnormal_cell_migration | 0.85662466 |
| 93 | MP0003045_fibrosis | 0.85094988 |
| 94 | MP0004019_abnormal_vitamin_homeostasis | 0.84697577 |
| 95 | MP0005164_abnormal_response_to | 0.83610770 |
| 96 | MP0003633_abnormal_nervous_system | 0.81244136 |
| 97 | MP0002896_abnormal_bone_mineralization | 0.80498972 |
| 98 | MP0005083_abnormal_biliary_tract | 0.79957743 |
| 99 | MP0000767_abnormal_smooth_muscle | 0.79830275 |
| 100 | MP0002396_abnormal_hematopoietic_system | 0.78743277 |
| 101 | MP0000249_abnormal_blood_vessel | 0.78477187 |
| 102 | MP0003828_pulmonary_edema | 0.76530597 |
| 103 | MP0001851_eye_inflammation | 0.74997442 |
| 104 | MP0008438_abnormal_cutaneous_collagen | 0.73427476 |
| 105 | MP0002933_joint_inflammation | 0.72738419 |
| 106 | MP0005595_abnormal_vascular_smooth | 0.72291363 |
| 107 | MP0003632_abnormal_nervous_system | 0.71150293 |
| 108 | MP0001849_ear_inflammation | 0.66299934 |
| 109 | MP0001873_stomach_inflammation | 0.66062841 |
| 110 | MP0005023_abnormal_wound_healing | 0.64161707 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.63426624 |
| 112 | MP0003795_abnormal_bone_structure | 0.63312749 |
| 113 | MP0000609_abnormal_liver_physiology | 0.61268516 |
| 114 | MP0000383_abnormal_hair_follicle | 0.60887882 |
| 115 | MP0003195_calcinosis | 0.59784658 |
| 116 | MP0003763_abnormal_thymus_physiology | 0.59586053 |
| 117 | MP0010678_abnormal_skin_adnexa | 0.59565841 |
| 118 | MP0010352_gastrointestinal_tract_polyps | 0.59421890 |
| 119 | MP0000747_muscle_weakness | 0.59268207 |
| 120 | MP0003705_abnormal_hypodermis_morpholog | 0.56128775 |
| 121 | MP0003186_abnormal_redox_activity | 0.54668092 |
| 122 | MP0000627_abnormal_mammary_gland | 0.54377177 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.54294719 |
| 124 | MP0003656_abnormal_erythrocyte_physiolo | 0.53118281 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.52932534 |
| 126 | MP0002168_other_aberrant_phenotype | 0.52172259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.72436765 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.39397859 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.14406062 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.14871882 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.70782431 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 4.66234748 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.47511334 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.38122587 |
| 9 | Neurofibrillary tangles (HP:0002185) | 4.37722772 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 4.34725500 |
| 11 | Mutism (HP:0002300) | 4.11260316 |
| 12 | Orchitis (HP:0100796) | 4.08743421 |
| 13 | Recurrent skin infections (HP:0001581) | 4.06857116 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 3.99477055 |
| 15 | Optic neuritis (HP:0100653) | 3.99477055 |
| 16 | Myositis (HP:0100614) | 3.95391856 |
| 17 | Gingivitis (HP:0000230) | 3.85332825 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.82125376 |
| 19 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.80671366 |
| 20 | Increased cerebral lipofuscin (HP:0011813) | 3.76098666 |
| 21 | Stomatitis (HP:0010280) | 3.68822991 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.65332853 |
| 23 | Prostate neoplasm (HP:0100787) | 3.63193996 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.55992734 |
| 25 | Vasculitis (HP:0002633) | 3.55473392 |
| 26 | Recurrent viral infections (HP:0004429) | 3.53109903 |
| 27 | Thick nail (HP:0001805) | 3.52917957 |
| 28 | Periodontitis (HP:0000704) | 3.52911124 |
| 29 | Glomerulonephritis (HP:0000099) | 3.43615883 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.18604059 |
| 31 | Obstructive lung disease (HP:0006536) | 3.18604059 |
| 32 | Retinal atrophy (HP:0001105) | 3.17909507 |
| 33 | Premature loss of primary teeth (HP:0006323) | 3.16522123 |
| 34 | Basal ganglia calcification (HP:0002135) | 3.12984749 |
| 35 | Increased IgM level (HP:0003496) | 3.11401098 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.09713195 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 3.09713195 |
| 38 | Cerebral inclusion bodies (HP:0100314) | 3.08371748 |
| 39 | Pustule (HP:0200039) | 2.99525274 |
| 40 | Diminished motivation (HP:0000745) | 2.91971336 |
| 41 | Apathy (HP:0000741) | 2.91654610 |
| 42 | Pulmonary infiltrates (HP:0002113) | 2.90766782 |
| 43 | Nuclear cataract (HP:0100018) | 2.90138994 |
| 44 | Myocardial infarction (HP:0001658) | 2.88073460 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.83254704 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.83254704 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.83254704 |
| 48 | Neuronal loss in central nervous system (HP:0002529) | 2.78393231 |
| 49 | Gingival bleeding (HP:0000225) | 2.74271691 |
| 50 | Hematochezia (HP:0002573) | 2.68748583 |
| 51 | Osteomyelitis (HP:0002754) | 2.68152340 |
| 52 | Axonal loss (HP:0003447) | 2.66695246 |
| 53 | Arterial thrombosis (HP:0004420) | 2.66290052 |
| 54 | Upper motor neuron abnormality (HP:0002127) | 2.64914053 |
| 55 | Leukocytosis (HP:0001974) | 2.59624242 |
| 56 | Urticaria (HP:0001025) | 2.58254601 |
| 57 | Tetraparesis (HP:0002273) | 2.53968236 |
| 58 | Nephritis (HP:0000123) | 2.53582870 |
| 59 | Chronic otitis media (HP:0000389) | 2.53444070 |
| 60 | Inappropriate behavior (HP:0000719) | 2.51486589 |
| 61 | Progressive neurologic deterioration (HP:0002344) | 2.51121228 |
| 62 | Agnosia (HP:0010524) | 2.50066557 |
| 63 | Recurrent pneumonia (HP:0006532) | 2.49330678 |
| 64 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.48443565 |
| 65 | Osteolytic defects of the hand bones (HP:0009699) | 2.48443565 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.47120720 |
| 67 | Amyloidosis (HP:0011034) | 2.46920563 |
| 68 | Cellulitis (HP:0100658) | 2.44583842 |
| 69 | Colitis (HP:0002583) | 2.43972165 |
| 70 | Hypergammaglobulinemia (HP:0010702) | 2.42291929 |
| 71 | Dysostosis multiplex (HP:0000943) | 2.41665647 |
| 72 | Bone pain (HP:0002653) | 2.41009182 |
| 73 | Pathologic fracture (HP:0002756) | 2.39537642 |
| 74 | Meningitis (HP:0001287) | 2.38735541 |
| 75 | Metaphyseal irregularity (HP:0003025) | 2.38281996 |
| 76 | Eosinophilia (HP:0001880) | 2.35872780 |
| 77 | Global brain atrophy (HP:0002283) | 2.35688857 |
| 78 | Recurrent lower respiratory tract infections (HP:0002783) | 2.29272608 |
| 79 | Gastrointestinal infarctions (HP:0005244) | 2.28557742 |
| 80 | Abnormality of the periventricular white matter (HP:0002518) | 2.26576488 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.25818902 |
| 82 | Complement deficiency (HP:0004431) | 2.24916091 |
| 83 | Dementia (HP:0000726) | 2.24880813 |
| 84 | Purpura (HP:0000979) | 2.24803592 |
| 85 | Joint hemorrhage (HP:0005261) | 2.24731494 |
| 86 | Asymmetric septal hypertrophy (HP:0001670) | 2.21440763 |
| 87 | Abnormality of complement system (HP:0005339) | 2.20319448 |
| 88 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.20131013 |
| 89 | Increased CSF protein (HP:0002922) | 2.19739456 |
| 90 | Polyneuropathy (HP:0001271) | 2.16755062 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.14734174 |
| 92 | Disinhibition (HP:0000734) | 2.13380457 |
| 93 | Porencephaly (HP:0002132) | 2.12619410 |
| 94 | Hemoptysis (HP:0002105) | 2.12610045 |
| 95 | Cardiomegaly (HP:0001640) | 2.11503473 |
| 96 | Abnormality of the prostate (HP:0008775) | 2.11304181 |
| 97 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.10196534 |
| 98 | Vertebral compression fractures (HP:0002953) | 2.09615435 |
| 99 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08577426 |
| 100 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08577426 |
| 101 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08577426 |
| 102 | Anorexia (HP:0002039) | 2.07030705 |
| 103 | Hepatosplenomegaly (HP:0001433) | 2.06981329 |
| 104 | Conjunctival telangiectasia (HP:0000524) | 2.06417923 |
| 105 | Personality changes (HP:0000751) | 2.04333899 |
| 106 | Acrocyanosis (HP:0001063) | 2.03150987 |
| 107 | Supranuclear gaze palsy (HP:0000605) | 2.01043270 |
| 108 | Mucopolysacchariduria (HP:0008155) | 2.00365145 |
| 109 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00365145 |
| 110 | Spondylolisthesis (HP:0003302) | 1.99947371 |
| 111 | Absent frontal sinuses (HP:0002688) | 1.99892193 |
| 112 | Prolonged neonatal jaundice (HP:0006579) | 1.98673365 |
| 113 | Interstitial pulmonary disease (HP:0006530) | 1.98304386 |
| 114 | Loss of speech (HP:0002371) | 1.96935572 |
| 115 | Beaking of vertebral bodies (HP:0004568) | 1.93952778 |
| 116 | Granulocytopenia (HP:0001913) | 1.93039550 |
| 117 | Peritonitis (HP:0002586) | 1.92529573 |
| 118 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.91424859 |
| 119 | Arthralgia (HP:0002829) | 1.90904175 |
| 120 | Inflammation of the large intestine (HP:0002037) | 1.90408308 |
| 121 | Xanthomatosis (HP:0000991) | 1.90270979 |
| 122 | Increased serum ferritin (HP:0003281) | 1.89271715 |
| 123 | Peripheral demyelination (HP:0011096) | 1.88839116 |
| 124 | Joint swelling (HP:0001386) | 1.86041073 |
| 125 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84467462 |
| 126 | Petechiae (HP:0000967) | 1.83533268 |
| 127 | Pulmonary artery stenosis (HP:0004415) | 1.82631609 |
| 128 | Progressive visual loss (HP:0000529) | 1.81817025 |
| 129 | Epistaxis (HP:0000421) | 1.80464547 |
| 130 | Esophageal varix (HP:0002040) | 1.79749128 |
| 131 | Nausea (HP:0002018) | 1.76947669 |
| 132 | Skin ulcer (HP:0200042) | 1.76744573 |
| 133 | Panhypogammaglobulinemia (HP:0003139) | 1.73562204 |
| 134 | Malnutrition (HP:0004395) | 1.72580029 |
| 135 | Restrictive lung disease (HP:0002091) | 1.71571098 |
| 136 | Increased IgE level (HP:0003212) | 1.70831080 |
| 137 | Spinal cord lesions (HP:0100561) | 1.70160696 |
| 138 | Memory impairment (HP:0002354) | 1.68807680 |
| 139 | Thoracic kyphosis (HP:0002942) | 1.68725806 |
| 140 | Cerebral hemorrhage (HP:0001342) | 1.68374529 |
| 141 | Mucosal telangiectasiae (HP:0100579) | 1.65725348 |
| 142 | Ovoid vertebral bodies (HP:0003300) | 1.63120808 |
| 143 | Anhidrosis (HP:0000970) | 1.62459617 |
| 144 | Multiple enchondromatosis (HP:0005701) | 1.62252599 |
| 145 | Protuberant abdomen (HP:0001538) | 1.57509322 |
| 146 | Urinary incontinence (HP:0000020) | 1.56791581 |
| 147 | Glomerulopathy (HP:0100820) | 1.53409570 |
| 148 | Skin nodule (HP:0200036) | 1.53324854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.85205825 |
| 2 | IRAK3 | 3.96259424 |
| 3 | TYK2 | 3.90725534 |
| 4 | IRAK4 | 3.56182312 |
| 5 | TBK1 | 3.52856039 |
| 6 | RIPK4 | 3.48605444 |
| 7 | DDR2 | 3.44460064 |
| 8 | IKBKE | 3.34980748 |
| 9 | BLK | 2.85739099 |
| 10 | ACVR1B | 2.82172586 |
| 11 | IKBKB | 2.69087553 |
| 12 | JAK1 | 2.63195724 |
| 13 | JAK3 | 2.51994987 |
| 14 | KIT | 2.40891224 |
| 15 | MAP3K13 | 2.26917382 |
| 16 | ERN1 | 2.14409485 |
| 17 | CAMKK2 | 2.03928907 |
| 18 | MAP4K1 | 2.00235938 |
| 19 | TXK | 2.00150239 |
| 20 | TGFBR2 | 1.86222219 |
| 21 | CHUK | 1.76838180 |
| 22 | TAOK3 | 1.70496723 |
| 23 | PBK | 1.62969790 |
| 24 | CSF1R | 1.59432399 |
| 25 | NEK9 | 1.53906478 |
| 26 | EIF2AK2 | 1.44872568 |
| 27 | CDC42BPA | 1.40698742 |
| 28 | EPHB1 | 1.32830806 |
| 29 | CSK | 1.32651977 |
| 30 | PIM2 | 1.30925543 |
| 31 | HCK | 1.29681411 |
| 32 | TESK1 | 1.24778259 |
| 33 | MAP3K11 | 1.24592672 |
| 34 | PDGFRA | 1.20069989 |
| 35 | SYK | 1.18391359 |
| 36 | RPS6KA4 | 1.18312765 |
| 37 | PDK2 | 1.15493244 |
| 38 | FGFR4 | 1.14696947 |
| 39 | BMPR2 | 1.12720166 |
| 40 | ZAP70 | 1.12426806 |
| 41 | JAK2 | 1.11300707 |
| 42 | LYN | 1.08198025 |
| 43 | CDK12 | 1.03549861 |
| 44 | LIMK1 | 1.03297548 |
| 45 | TAOK1 | 1.03274148 |
| 46 | GRK7 | 1.03080707 |
| 47 | PAK4 | 1.02405723 |
| 48 | LCK | 1.02292579 |
| 49 | PIM1 | 1.01622090 |
| 50 | BTK | 0.99588964 |
| 51 | EPHA3 | 0.95925947 |
| 52 | FGR | 0.94387390 |
| 53 | MAP3K12 | 0.94281757 |
| 54 | CAMK1D | 0.93318288 |
| 55 | TGFBR1 | 0.93267810 |
| 56 | MATK | 0.89632489 |
| 57 | FGFR3 | 0.86412092 |
| 58 | YES1 | 0.85786146 |
| 59 | IRAK1 | 0.85482577 |
| 60 | MARK3 | 0.83391911 |
| 61 | TEC | 0.81401090 |
| 62 | STK3 | 0.81052917 |
| 63 | STK4 | 0.80935966 |
| 64 | STK24 | 0.80933403 |
| 65 | MAP3K1 | 0.80080216 |
| 66 | FES | 0.77852509 |
| 67 | PRPF4B | 0.77645274 |
| 68 | PTK6 | 0.77424404 |
| 69 | ARAF | 0.76500193 |
| 70 | TESK2 | 0.76498557 |
| 71 | MST4 | 0.76217971 |
| 72 | NUAK1 | 0.75996624 |
| 73 | EGFR | 0.73119635 |
| 74 | MAP3K5 | 0.70830232 |
| 75 | TRPM7 | 0.70419675 |
| 76 | STK10 | 0.69814141 |
| 77 | IRAK2 | 0.69514667 |
| 78 | BMX | 0.67841773 |
| 79 | CDK6 | 0.66332294 |
| 80 | ADRBK2 | 0.65134641 |
| 81 | PDPK1 | 0.63218397 |
| 82 | TTN | 0.61389282 |
| 83 | ABL1 | 0.60742146 |
| 84 | PDGFRB | 0.58318152 |
| 85 | DAPK2 | 0.56254711 |
| 86 | PRKG2 | 0.56067270 |
| 87 | ITK | 0.55348458 |
| 88 | SCYL2 | 0.53254811 |
| 89 | MAP3K2 | 0.52935471 |
| 90 | PRKCD | 0.52590258 |
| 91 | SIK2 | 0.49839223 |
| 92 | MST1R | 0.48246065 |
| 93 | RPS6KA2 | 0.46027367 |
| 94 | CLK1 | 0.45788835 |
| 95 | PDK1 | 0.45739287 |
| 96 | MAP2K6 | 0.45525055 |
| 97 | MAP2K3 | 0.43591125 |
| 98 | KSR1 | 0.43325816 |
| 99 | FLT3 | 0.42714576 |
| 100 | ABL2 | 0.42133713 |
| 101 | ERBB4 | 0.41824861 |
| 102 | RPS6KL1 | 0.41147514 |
| 103 | RPS6KC1 | 0.41147514 |
| 104 | TYRO3 | 0.39825774 |
| 105 | CAMKK1 | 0.39658319 |
| 106 | MAPK7 | 0.38875729 |
| 107 | MAPKAPK2 | 0.38618455 |
| 108 | TAOK2 | 0.38150744 |
| 109 | PIK3CG | 0.37326381 |
| 110 | CAMK1G | 0.36734242 |
| 111 | PRKCQ | 0.36550590 |
| 112 | MAP3K10 | 0.35554924 |
| 113 | EPHB2 | 0.33195260 |
| 114 | MAPK11 | 0.31868853 |
| 115 | DAPK3 | 0.31544744 |
| 116 | MAPK4 | 0.31479147 |
| 117 | MOS | 0.31401413 |
| 118 | IGF1R | 0.30500858 |
| 119 | MAP3K3 | 0.30002248 |
| 120 | SIK3 | 0.29973091 |
| 121 | NME2 | 0.29610850 |
| 122 | RPS6KA6 | 0.29212552 |
| 123 | LATS2 | 0.28952155 |
| 124 | RIPK1 | 0.28779149 |
| 125 | PKN1 | 0.27721437 |
| 126 | GSK3A | 0.25241482 |
| 127 | SGK1 | 0.24658125 |
| 128 | RPS6KA5 | 0.24064805 |
| 129 | MAP3K9 | 0.24057405 |
| 130 | ZAK | 0.23629031 |
| 131 | PRKAA2 | 0.23222629 |
| 132 | SIK1 | 0.22608012 |
| 133 | FYN | 0.21581957 |
| 134 | LATS1 | 0.20713071 |
| 135 | PLK2 | 0.19399421 |
| 136 | INSR | 0.18967355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.36134674 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.24471023 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.00396075 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.82404818 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.66905585 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.61156272 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.53973744 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.53865462 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.44642463 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.43690066 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.41547966 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.34438532 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 2.25530748 |
| 14 | Influenza A_Homo sapiens_hsa05164 | 2.23171212 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.15841980 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 2.05611022 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.04349995 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.92624258 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87779192 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.84603598 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.77157019 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.72061906 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.71679541 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66396094 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.65412238 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.59734506 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.58963543 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53561341 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51769492 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47777370 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.47056351 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43993539 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.39724136 |
| 34 | Hepatitis C_Homo sapiens_hsa05160 | 1.35234204 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34167559 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29779167 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26095077 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.25750648 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.25244851 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.23372825 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23155585 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21801203 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21151608 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.16682662 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.14565636 |
| 46 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13914851 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 1.09853654 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08472477 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.06497111 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03062492 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 0.90312651 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87368261 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.85257124 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83434776 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80573443 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77282329 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74844774 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74492167 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.73383961 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71854737 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71690289 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71255629 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70024260 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67441572 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63230234 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63040475 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62799844 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.59307477 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58960558 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58069431 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.57169355 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54955499 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53992935 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50559972 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49472926 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49217802 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.48709365 |
| 78 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.48568947 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44107305 |
| 80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43849484 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.43121581 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37467717 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.37242164 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36250753 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34925470 |
| 86 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34351039 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34130134 |
| 88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33582142 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30517744 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30447798 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28795645 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28507925 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27663425 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27207606 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.27012442 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26338458 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.25816107 |
| 98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.25101377 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24702201 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24249121 |
| 101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23801852 |
| 102 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.23014482 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21836132 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20972528 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20479331 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.19703053 |
| 107 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.19623155 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.18163096 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.16819814 |
| 110 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.16253891 |
| 111 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.16248475 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16046822 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14960077 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.14418063 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14417199 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.12637671 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.09394981 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.08634556 |

